Copy number variations in regions encompassing important prostate cancer genes, such as PTEN and CHD1 or ASAP1, MYC, and HDAC9, are predictive of cancer significance and represent useful biomarkers to distinguish low-risk prostate cancer from intermediate- and high-risk prostate cancer [86]. This evidence concerns the gene ASAP1 and prostate cancer.